These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8148464)

  • 1. Pathogenesis and potential strategies for prevention and treatment of septic shock: an update.
    Glauser MP; Heumann D; Baumgartner JD; Cohen J
    Clin Infect Dis; 1994 Feb; 18 Suppl 2():S205-16. PubMed ID: 8148464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current understanding of the pathogenesis of gram-negative shock.
    Waage A; Brandtzaeg P; Espevik T; Halstensen A
    Infect Dis Clin North Am; 1991 Dec; 5(4):781-91. PubMed ID: 1783767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New strategies in nonantibiotic treatment of gram-negative sepsis.
    Cohn J; Bone RC
    Cleve Clin J Med; 1992; 59(6):608-15. PubMed ID: 1424072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shock.
    Calandra T; Baumgartner JD; Glauser MP
    Prog Clin Biol Res; 1991; 367():141-59. PubMed ID: 1924424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Monoclonal antibodies in the treatment of septic shock].
    Trilla A; Alonso P
    Med Clin (Barc); 1992 Dec; 99(20):778-80. PubMed ID: 1460950
    [No Abstract]   [Full Text] [Related]  

  • 6. [The application of molecular biology to anti-endotoxin therapies].
    Someya T; Sasaki K; Hirata K
    Nihon Geka Gakkai Zasshi; 2003 Jul; 104(7):523-6. PubMed ID: 12884777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic therapy for ARDS, septic shock, and multiple-organ failure.
    St John RC; Dorinsky PM
    Chest; 1993 Mar; 103(3):932-43. PubMed ID: 8449096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possibilities of immunoprophylaxis and immunotherapy in gut-derived infectious-toxic shock (GITS).
    Imbach P; Hässig A; Cottier H
    Curr Stud Hematol Blood Transfus; 1992; (59):301-23. PubMed ID: 1572217
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cytokines and septic shock. New perspectives on its treatment].
    Zamora Madaria E
    An Med Interna; 1993 Dec; 10(12):573-5. PubMed ID: 8049320
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapies for sepsis. Emerging therapies for sepsis and septic shock.
    Abraham E
    West J Med; 1997 Mar; 166(3):195-200. PubMed ID: 9143195
    [No Abstract]   [Full Text] [Related]  

  • 11. Endotoxin as a therapeutic target in septic shock.
    Corriveau CC; Danner RL
    Infect Agents Dis; 1993 Feb; 2(1):35-43. PubMed ID: 8162352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies and the treatment of gram-negative bacteremia and shock.
    Wolff SM
    N Engl J Med; 1991 Feb; 324(7):486-8. PubMed ID: 1988835
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapies directed against endotoxin--has the time come?
    Quezado ZM; Hoffman WD
    West J Med; 1993 Apr; 158(4):424-5. PubMed ID: 8317138
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiendotoxin antibodies: a dead end?
    Cross AS
    Ann Intern Med; 1994 Jul; 121(1):58-60. PubMed ID: 8198349
    [No Abstract]   [Full Text] [Related]  

  • 15. Endotoxemia and gram-negative bacteremia in swine: chemical mediators and therapeutic considerations.
    Olson NC; Dodam JR; Kruse-Elliott KT
    J Am Vet Med Assoc; 1992 Jun; 200(12):1884-93. PubMed ID: 1639693
    [No Abstract]   [Full Text] [Related]  

  • 16. "Monoclonal antibodies for septic shock: in or out of the barn door?".
    Goldstein B
    QRB Qual Rev Bull; 1992 Feb; 18(2):42. PubMed ID: 1574318
    [No Abstract]   [Full Text] [Related]  

  • 17. Antiendotoxin antibodies.
    Siegel JP
    Ann Intern Med; 1995 Feb; 122(4):315-6. PubMed ID: 7825773
    [No Abstract]   [Full Text] [Related]  

  • 18. Mediators of septic shock: new approaches for interrupting the endogenous inflammatory cascade.
    Giroir BP
    Crit Care Med; 1993 May; 21(5):780-9. PubMed ID: 8482101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bacterial endotoxins and their effects].
    Bertók L
    Orv Hetil; 1998 Aug; 139(33):1947-53. PubMed ID: 9734211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiendotoxin therapies for septic shock.
    Corriveau CC; Danner RL
    Infect Agents Dis; 1993 Feb; 2(1):44-52. PubMed ID: 8162353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.